26 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
core principles of modular innovation with protein-based cell programming focused on advanced targeting, pharmacological control and enhancement … Competition and Innovation Act amended the PHSA to authorize the FDA to approve similar versions of innovative biologics, commonly known as biosimilars
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
13 Feb 24
Regulation FD Disclosure
4:06pm
programs * BioNTech holds an option to co-fund and co-commercialize * *
A broad toolkit which is core to our strategy of modular innovation Viral
424B5
AUTL
Autolus Therapeutics plc
9 Dec 22
Prospectus supplement for primary offering
5:40pm
, refocusing such programs towards innovation in the U.K. On July 21, 2022, draft legislation was published setting out, among other things, details … 2022.
Our Pipeline
Our product pipeline is built on our core principles of modular innovation with protein-based cell programming focused on advanced
424B5
AUTL
Autolus Therapeutics plc
8 Dec 22
Prospectus supplement for primary offering
4:10pm
intention to introduce further restrictions to the U.K. research and development relief programs, refocusing such programs towards innovation … product pipeline is built on our core principles of modular innovation with protein-based cell programming focused on advanced targeting, pharmacological
6-K
EX-99.4
m9jzcm6sikk
8 Nov 21
Securities Purchase Agreement
5:28pm
424B5
k8a xsiwn
19 Aug 21
Prospectus supplement for primary offering
4:13pm
F-3
j0a5i5tq77gz1
6 Aug 21
Shelf registration (foreign)
2:30pm
6-K
EX-1
pvxhaozb14w6pr77fo
30 Jun 21
Annual Report and Accounts
6:05am
424B5
w77cnpk
11 Feb 21
Prospectus supplement for primary offering
5:16pm
424B5
6th0 pltzck85h
8 Feb 21
Prospectus supplement for primary offering
5:27pm
424B5
d12 p0ax8lxil
18 Sep 20
Prospectus supplement for primary offering
8:01am
6-K
EX-1
2fptrar6keq
26 May 20
Current report (foreign)
4:31pm
424B5
1w73 z7u9lmnk3t
24 Jan 20
Prospectus supplement for primary offering
4:11pm
424B5
ac3d4p73 zm
22 Jan 20
Prospectus supplement for primary offering
5:30pm
424B4
vbh81 dak7m
11 Apr 19
Prospectus supplement with pricing info
4:10pm
F-1
v1p32kenv6t79
8 Apr 19
Registration statement (foreign)
4:34pm
20-F
j3643068t hldxljhu27
23 Nov 18
Annual report (foreign)
12:00am